Issue 3: When is the best time to connect with HCPs about a new launch?
Welcome to the 3rd in our Navigator365™ Insights series. Designed to explore key concepts in omnichannel engagement and demonstrate practical uses of Navigator365™, these were sent as emails to help our active users harness the full power of the platform, but the valuable insights they offer are just as relevant to anyone involved in omnichannel strategy and engagement.
With 40% of worldwide drug launches failing to meet their 2-year sales forecast, it’s clear that the product landscape has never looked so unforgiving. And when it comes to launching a new product, there’s only one chance to get it right…
So what is the best time to connect with HCPs about a new launch?
When we ask over 4500 European specialists when they would first like to engage digitally with pharma prior to a product launch, more than 1-in-3 say prior to launch. This opens a critical window for Market Access and Medical teams to connect early with this crucial audience of potential innovators and early adopters – well before Commercial can enter the picture.
Omnichannel opportunities can help you increase reach, frequency and impact of your key disease education messages, while learnings from the market during this time can also ensure Commercial has their own campaign ready to go on day 1 post-approval.
These and many other insights can be found using your active Navigator365™ Core licenses.
Navigator365™ Insights is just part of our commitment to ensuring our users get the most out of their data. Stay tuned for more Navigator365™ Insights and empower your journey to omnichannel excellence.
Already an active Navigator365™ user? Why not dive into your insights right now!
Interested in finding out more about how the Navigator365™ offering can deliver an unparalleled head start for your next customer engagement plan? Then please get in touch!
